Click here to read about our 2010 grant recipients.
Click here to read about past grant recipients.
The application period for our 2011 Young Investigator Research Grant competition is now open! Click here for more information.
Funding cutting-edge lung cancer research is essential to helping patients live longer and better lives. Over the past five years, National Lung Cancer Partnership has funded over $1.5 million in research dollars.
Lung cancer is severely underfunded by the government compared with other major cancer killers. To understand how underfunded this disease is, and why private research funding is so important, click here to see a chart comparing cancer fatalities to type and government funding.
National Lung Cancer Partnership is currently supporting a Young Investigator Research Grant for junior clinical and basic investigators involved in lung cancer etiology, prevention, and treatment. National Lung Cancer Partnership is sponsoring this program to ensure effective translation of basic and behavioral research discoveries into patient therapies to reduce lung cancer incidence, morbidity and mortality.
The National Lung Cancer Partnership's Grants & Awards are peer-reviewed by members of our Scientific Executive Committee and additional prominent lung cancer researchers. Grant applications are reviewed using a process similar to the National Institutes of Health (NIH) peer-review system.
The goal of the NIH peer-review system is to provide a fair and unbiased evaluation of applications. Each grant application is evaluated by multiple scientists who have expertise in relevant scientific disciplines and research areas. In addition, National Lung Cancer Partnership includes patient advocates in the review process to enhance the scientific reviews by providing a patient and public perspective. This review system ensures that our donors support the best possible research.
National Lung Cancer Partnership has been pleased to partner with the Lance Armstrong Foundation, Oncology Nursing Society Foundation (ONS), and the International Association for the Study of Lung Cancer (IASLC) to fund more promising lung cancer research that will ultimately fulfill our mission of decreasing deaths due to lung cancer, and helping patients live longer and better lives.
